IL-2 antibodies in type 1 diabetes and during IL-2 therapy-MedSci.cn

IL-2 antibodies in type 1 diabetes and during IL-2 therapy

Churlaud, G; Rosenzwajg, M; Cacoub, P; Saadoun, D; Valteau-Couanet, D; Chaput, N; Pugliese, A; Klatzmann, D

Klatzmann, D (reprint author), Grp Hosp Pitie Salpetriere, AP HP, Biotherapy CIC BTi, Paris, France.; Klatzmann, D (reprint author), Inflammat Immunopathol Biotherapy Dept i2B, Paris, France.; Klatzmann, D (reprint author), Sorbonne Univ, INSERM, Immunol